These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 6085856)

  • 1. The impact of new technologies on vaccine development.
    Winther MD; Dougan G
    Biotechnol Genet Eng Rev; 1984; 2():1-39. PubMed ID: 6085856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biotechnological approach to a new foot-and-mouth disease virus vaccine.
    Küpper H
    Biotechnol Genet Eng Rev; 1984; 1():223-59. PubMed ID: 6085855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fish vaccine antigens produced or delivered by recombinant DNA technologies.
    Leong JC; Anderson E; Bootland LM; Chiou PW; Johnson M; Kim C; Mourich D; Trobridge G
    Dev Biol Stand; 1997; 90():267-77. PubMed ID: 9270855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New approaches to vaccine development: memorandum from a WHO meeting.
    Bull World Health Organ; 1985; 63(3):479-84. PubMed ID: 3876169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of bacillus Calmette-Guerin and recombinant bacillus Calmette-Guerin in vaccine development and tumor immunotherapy.
    Zheng YQ; Naguib YW; Dong Y; Shi YC; Bou S; Cui Z
    Expert Rev Vaccines; 2015; 14(9):1255-75. PubMed ID: 26268434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant vaccine delivery systems and encoded vaccines.
    Stover CK
    Curr Opin Immunol; 1994 Aug; 6(4):568-71. PubMed ID: 7946044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prospects and achievements of genetic engineering in development of antiviral vaccines].
    Tikhonenko TI
    Mol Biol (Mosk); 1984; 18(1):176-88. PubMed ID: 6323971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological safety concepts of genetically modified live bacterial vaccines.
    Frey J
    Vaccine; 2007 Jul; 25(30):5598-605. PubMed ID: 17239999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New aspects of vaccine development.
    Liew FY
    Clin Exp Immunol; 1985 Nov; 62(2):225-41. PubMed ID: 2417761
    [No Abstract]   [Full Text] [Related]  

  • 10. Strategies of constructing recombinant vaccines.
    Sałamaszyńska-Guz A; Klimuszko D
    Pol J Vet Sci; 2009; 12(1):133-9. PubMed ID: 19459451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Modifications of Icosahedral Plant Virus-based Nanoparticles for Vaccine and Immunotherapy Applications.
    Narayanan KB; Han SS
    Curr Protein Pept Sci; 2017 Aug; 18(11):1141-1151. PubMed ID: 28440187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Viral vaccines produced by gene technology and synthesis].
    Hess RG
    Tierarztl Prax; 1986; 14(1):9-14. PubMed ID: 2424142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Newer directions in vaccine development and utilization.
    Hilleman MR
    J Infect Dis; 1985 Mar; 151(3):407-19. PubMed ID: 2982958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategy for producing new foot-and-mouth disease vaccines that display complex epitopes.
    McKenna TS; Rieder E; Lubroth J; Burrage T; Baxt B; Mason PW
    J Biotechnol; 1996 Jan; 44(1-3):83-9. PubMed ID: 8717390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and immunogenicity of recombinant GapA(+) Mycoplasma gallisepticum vaccine strain ts-11 expressing infectious bronchitis virus-S1 glycoprotein and chicken interleukin-6.
    Shil PK; Kanci A; Browning GF; Markham PF
    Vaccine; 2011 Apr; 29(17):3197-205. PubMed ID: 21354248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetically engineered vaccines: an overview.
    Dertzbaugh MT
    Plasmid; 1998; 39(2):100-13. PubMed ID: 9514708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.
    Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant vaccinia viruses as new live vaccines.
    Smith GL; Mackett M; Moss B
    Biotechnol Genet Eng Rev; 1984; 2():383-407. PubMed ID: 6100668
    [No Abstract]   [Full Text] [Related]  

  • 19. Genetically engineered vaccines: problems and promises.
    Brown F; Dougan G; Snary D
    Microbiol Sci; 1984 Aug; 1(5):123-7. PubMed ID: 6444113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malaria vaccine.
    Khurana SK; Talib VH
    Indian J Pathol Microbiol; 1996 Dec; 39(5):433-41. PubMed ID: 9002371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.